Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars
    3. >
  3. Dermatology

Journal
Presentation
    （Last updated : 2023-05-20 21:13:12）
  Natsuaki Masaru
   Department   Specialty Division  Dermatology, Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Optimal patch application time in the evaluation of skin irritation 2013/05 Link
2. Introduction　 Kampo treatment for allergic skin diseases 2014/08
3. Case report　 Case of tick-associated rash illness caused by Amblyomma testudinarium 2014/09 Link
4. Original article　 Assessment of fever for infection control using thermography - facial thermography in patients with influenza - 2015/01
5. Case report　 Allergic contact dermatitis due to ripasudil hydrochloride hydrate in eye-drops: A case report 2018/02
6. Case report　 Two cases of Japanese spotted fever infected in Rokko mountain near urban area of southern Hyogo Prefecture 2018/06 Link
7. Case report　 Anaphylaxis caused by a centipede bite: A "true" type-I allergic reaction 2018/07 Link
8. Case report　 A case of photoallergic dermatitis caused by pirfenidone 2018/10 Link
9. Original article　 Epidemiological survey of tick bites occurring in Hyogo Prefecture from 2014
through 2018 2020/03 Link
10. Original article　 Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan 2020/04 Link
11. Original article　 Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice. 2021/10 Link
12. Original article　 Dupilumab in atopic dermatitis patients with chronic hepatitis B 2022/04 Link
13. Original article　 Evaluation of long-term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real-world clinical practice 2022/04 Link
14. Original article　 Single-cell RNA sequencing of mycosis fungoides reveals a cluster of actively proliferating lymphocytes 2022/05 Link
15. Original article　 Atopic dermatitis patients may maintain long-term remission after discontinuation of dupilumab 2022/06 Link
Display 5 items
Display all(15)
■ Presentation
1. Tick-associated rash illness  2014/07/17
2. Dupilumab’s Effects on Circulating Group 2 Innate Lymphoid Cell and T Helper Type 2 Cell Populations in Patients with Atopic Dermatitis  2020/12/13
mail